Status:
WITHDRAWN
Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lymphoma
Eligibility:
All Genders
Brief Summary
RATIONALE: Studying samples of blood in the laboratory from patients who have undergone a donor bone marrow transplant may help doctors learn more about changes that occur in DNA and identify biomarke...
Detailed Description
OBJECTIVES: Primary * Identify detectable changes in the transcriptomic or proteomic expression prior to clinical manifestations of graft-versus-host disease (GVHD) in blood samples from at-risk pat...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Any patient undergoing an allogeneic bone marrow transplantation at one of the participating Mayo Clinic sites
- PATIENT CHARACTERISTICS:
- Body weight ≥ 15 kg
- Not pregnant
- Not a prisoner
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00898612
Start Date
March 1 2008
Last Update
March 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Arizona
Scottsdale, Arizona, United States, 85259-5499